Batzelladines O and P were equally active in docetaxel-sensitive and -resistant prostate cancer cells, despite the slight p-glycoprotein substrate-like activity, and exhibited an additive effect in combination with docetaxel. This evidence concerns the gene ABCB1 and prostate carcinoma.